Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
ConditionLiver Dysfunction
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Alberta
About this trial
INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and outcomes. A segment of a biopsy performed as standard-of-care for indications, or by center protocol, will be used for gene expression study.
Eligibility criteria
Qualifiers
biopsy for clinical indications
Disqualifiers
no consent, pregnant women
Trial design
Treatments tested in this trial
- liver biopsy
Treatment groups
No treatment groups listed
Locations
15Australia
Centenary Institute of Cancer Medicine & Cell Biology, Royal Prince Alfred HospitalNSW 2050, Camperdown Australia
Canada
University of Alberta, Laboratory Medicine and PathologyT6G 2R7, EdmontonAlberta, Canada
Poland
Dep. of Nephrology, Transplantation & Internal Med., Samodzielny Publiczny Szpital Kliniczny im. A. Mieleckiego40-027, Katowice Poland
Independent Public Composite Regional Hospital71-455, Szczecin Poland
Sponsors and collaborators
University of Alberta
Lead sponsor
Source ClinicalTrials.gov